In hepatocellular carcinoma, the most common form of primary liver cancer, AKR1B1 has been shown to bind the kinase domain of AKT1, leading to activation of the AKT/mTOR pathway. This evidence concerns the gene AKR1B1 and hepatocellular carcinoma.